The Board of directors manages the Foundation and ensure that its assets are devoted to the meet the objectives of the Foundation.
The Board adopts the regulations necessary for its own running and the running of the Foundation in general.
The Board establishes the budget for each accounting period and publishes an annual written report on its management. It approves the annual Balance Sheet and Profit and Loss Account.
Professor, University of Neuchâtel and HSeT’s President.
Professor of Health Law at the Law Faculty of the University of Neuchâtel (Switzerland). Founder and Deputy Director of the Institute of Health Law of the University of Neuchâtel, one of the 5 academic centers of the World Medical Association since 2013.
He was invited professor at the University of Montreal (Canada) in 2002 and at the National Tsing Hua University (Taiwan) in 2014. He is vice-director of the Swiss School of Public Health (SSPH+) and of the Ecole Romande de santé publique(ERSP) and also vice-president of the Board of the Réseau Fribourgeois de Santé Mentale, (RFSM) Expert in legisprudence, he collaborated in the drafting of several legislations in the field of health and healthcare at the Swiss and European level. He is also regularly invited by scientific and professional association in developing their guidelines in those fields. For instance, he coordinated the drafting of the Olympic Movement Medical Code for the IOC in 2006 and contributed to the 2008 and 2013 revision of the Declaration of Helsinki of the World Medical Association.
Expert in the field of patient’s rights and public health law with special interest in the regulation of research with human subjects, patient’s rights, the regulation of healthcare professionals, pharmaceutical and food stuff regulation, he has written more than 100 scientific publications, articles and book chapters on those issues. He is invited as expert by several organizations working in the field of health law and ethics at the national and international level (e.g. Swiss Academy of Medical Sciences, Council of Europe, European Union, World Medical Association, World Health Organization). He is one of the founder of the European Network of Research Ethics Committees supported by the European Commission. Since 2006, he is also the coordinator of the initiative Training and Resources in Research Ethics Evaluation (TRREE) which aims at providing a free, open access and multilingual online training program in research ethics and regulation.
MD PhD, CEO and coordinator of Microbiology and Oncology
Jean-Pierre Kraehenbuhl is the Chief Executive Officer of HSeT. He is emeritus Professor at the University of Lausanne, and was affiliated member of the Swiss Institute of Cancer Research (ISREC). He used to work on mucosal immunity and vaccinology. He was a co-founder of EuroVacc, a Foundation active in the development of HIV vaccines, He is a member of EMBO. He was the co- founder of OraVax, Inc, now part of Sanofi Pasteur. He is co-leader of OCTAVE, the Online Collaborative Training of AIDS Vaccine Evaluation.
Phone: +41 21 692 5856
Address: HSeT Foundation
c/o Center of Immunity and Infection (CIIL)
Chemin des Boveresses 155
CH-1066 Epalinges, Switzerland
PhD, Vice Dean of the Faculty of Biology and Medicine, University of Lausanne, Switzerland
Nicolas Fasel is full professor at the Faculty of Biology and Medicine of the University of Lausanne and director of the Department of Biochemistry. After a doctoral degree at the Swiss Institute for Experimental Cancer Research, he took up a post-doctoral position at UCLA. On his return to Switzerland, he studied post-translational modifications of cell surface antigens before investigating the molecular and cellular biology of protozoan parasites including virulence factors, cell death and host response. His work led to pioneer contributions of the role of Leishmania RNA virus (LRV) in the innate immune response in Leishmania infection and in exacerbating lesion development. He further reported techniques to identify LRV in Leishmania species and the presence of LRV in L. aethiopica. He is one of the world leaders in his field and has extensive expertise in Leishmania biology, in infection models and in the innate immune response of the host.
Vice Dean, Associate Professor, Antalgia center, Anesthesiology department University Hospital, Lausanne, Switzerland
Isabelle Décosterd, MD, is board certified in anesthesiology. She is Associate Professor at the Faculty of biology and medicine, UNIL and leads the Pain Center, Department of anesthesiology, CHUV. As the PI of the Pain Center’s research laboratory, she develops and manages fundamental and translational research to identify mechanisms and treatments of chronic pain. She also supports and fosters clinical research to evaluate, prevent and treat acute and chronic pain. Since 2016, she is Vice Dean for Education and Formation Affairs.
Phone: +41 79 556 64 77
MD, Director of Vaccine Studies at the San Francisco Department of Public Health
Jonathan Fuchs received an M.D. from the Robert Wood Johnson Medical School at the University of Medicine & Dentistry of New Jersey (New Brunswick, New Jersey, USA) and an M.P.H. from Columbia University (New York). He completed a residency in internal medicine at the University of California (San Francisco, California, USA) in 2000, and he is now Director of Vaccine Studies at the San Francisco Department of Public Health. He is an assistant clinical professor at the University of California (San Francisco) and co-chair of the Training Executive Committee for the HIV Vaccine Trials Network (Seattle, Washington, USA).
MD, Associate Professor of Internal Medicine and Nephrology at the Faculty of Medicine of the University of Bern
Uyen Huynh-Do is Associate Professor of Internal Medicine and Nephrology at the Faculty of Medicine of the University of Bern. She was trained as an MD at the University of Zurich, then specialized in renal physiology and hypertension. From 1996 to 1999 Uyen Huynh-Do joined the Division of Nephrology and the Vanderbilt Center for Vascular Biology at Vanderbilt University Medical Center (Nashville, TN) as a Postdoctoral Research Fellow. In 2004 she was appointed Assistant Professor, and in 2008 Associate Professor at the University Hospital of Bern. In 2009 she received a Master of Medical Education (MME) from the University of Bern and the Department of Medical Education, University of Illinois at Chicago. She is the director of the interuniversitary PhD and Postdoctoral programme IKPP (Integrative Kidney Physiology and Pathophysiology) supported by both the Swiss National Science Foundation and the European Union (Marie Curie FP7 Co-Fund).
MD, MHPE, Vice Dean, Professor of internal medicine & medical education, director of the Unit of Development & Research in Medical Education (UDREM), Geneva University Medical School
Mathieu Nendaz is an internist at the Geneva University Hospitals and trained in health professions education at the University of Illinois at Chicago. He is presently also Director of the Unit of Development and Research (UDREM) and Professor at the Faculty of Medicine, University of Geneva, Switzerland. His research interests include Internal Medicine and Medical Education. In this field, he is particularly interested in decision-making, clinical reasoning, clinical supervision, and interprofessional issues. He is deeply involved in direct teaching, clinical supervision and training, as well as in the development and organization of teaching concepts and medical curriculum.
MD, PhD, Professor, Swiss Federal Institute of Technology
Trained as an MD, William F. Pralong did his Thesis in Transport Phenomena at the Dpt of Pharmacology, School of Medicine in Geneva. He specialized then in Diabetes and Pancreas Physiology. He moved to industry to work on artificial pancreas and then conducted clinical trials in genetherapy for EPO delivery at the Dept of Experimental Surgery with Patrick Aebischer at the CHUV, Lausanne. He joined EPFL in 2000 with EPFL’s President, Patrick Aebischer to set up the curriculum in Life Sciences and Technology and in Bioengineering at the School of Life Sciences. Presently William Pralong is Deputy to the Provost for MQS at the Swiss Federal Institute of Technology.
Attorney at Kellerhals Carrard Law Firm, Lausanne, Switzterland
Dr Frédéric Rochat was admitted as an attorney-at-law to the bars of the Canton of Vaud (2002) and New York (2005). He is a partner at the law firm of Carrard & Associés in Lausanne, Switzerland, specializing in corporate and contract law. In parallel he teaches law at various institutions.
Prior to joining Carrard & Associés in 2007, Frédéric earned his law degree in 1996 from the universities of Lausanne and Berne. While working as a teaching and research assistant in the fields of contract and securities law he obtained his doctorate from the University of Lausanne in 2002. He completed his two-year attorney traineeship and worked as an associate for one additional year in a business law firm in Lausanne, before leaving for the U.S. to obtain an LL.M. degree from Columbia University. From 2004 to 2007 he worked in the M& A and securities departments of the law firm of Simpson Thacher & Bartlett LLP in New York (2004-2005) and London (2006-2007).
MD, coordinator of Nephrology, Pharmacology and Toxicology
Bernard Rossier, emeritus Professor and former Director of the Department of Pharmacology and Toxicology and former Dean of the Faculty of Biology and Medicine of the University of Lausanne, is presently leading a research group working in the field of hypertension. He is recipient of many international Prizes in the field of nephrology. He is a member of EMBO, the Academia Europaea, the deutsche Akademie der Naturforscher Leopoldina, and is a Foreign Honorary member of the American Academy of Arts and Sciences. He is Dr. honoris causa of the University Pierre et Marie Curie in Paris. He is member of the Louis Jeantet Foundation in Geneva and the Cloetta Foundation in Zurich.
MD, coordinator of Laboratory medicine, Hematology, Pharmacology and Toxicology
Michelle Rossier received an M.D. from the University of Lausanne (Switzerland) and completed a MD thesis medical Department of Physiology of the University of Geneva. After a postdoctoral research fellowship, she held an assistant research physiologist position at the Department of Physiology, University of California, San Francisco. She then returned to the Institute of Pharmacology at the University of Lausanne, where she became a « maître assistant ». From 1977 to 2006 she was Director of the clinical laboratories of Hematology, Clinical Chemistry and Microbiology at the Hospital of Morges, Switzerland. In 2001 she held the same position with Viollier Inc., one of the largest private clinical laboratories in Switzerland. She joined the HSeT core team in February 2006 to become a project coordinator for several HSeT projects.
Amadou Alpha Sall
PhD, director of the WHO collaborating center and scientific Director of the Institut Pasteur of Dakar
Amadou A Sall is a virologist and has a PhD in Public health. He received his scientific education at Universities Paul Sabatier at Toulouse, Paris Orsay and Pierre et Marie Curie in France. He has also visited several laboratories for his training including Institut Pasteur in Paris (France), Institute of Virology and environmental medicine in Oxford (United Kingdom), Center for tropical disease at the University of Texas Medical Branch at Galveston (USA) or Albert Einstein College of Medicine of Yeshiva University at New York. He is currently the head of the Arboviruses and viral hemorrhagic fever unit, director of the WHO collaborating center and scientific Director of Institut Pasteur de Dakar which belongs to the Institut Pasteur International Network. His research focused primarily on ecology and evolution of arboviruses and viral hemorrhagic fever and diagnostics of the latter viruses is a priority in his laboratory. Dr Sall has worked for 2 years in Cambodia on hepatitis B and C viruses. He was a Visiting Research Scientist at the Center for Infection and immunity at the Mailman School of Public health of Columbia University and worked for a year on pathogen discovery. He has published more than 90 papers and book chapters and give more than 150 scientific communications in international meetings.